Xie, X.; Frank, D.; Patnana, P.K.; Schütte, J.; Al-Matary, Y.; Liu, L.; Wei, L.; Dugas, M.; Varghese, J.; Nimmagadda, S.C.;
et al. Curcumin as an Epigenetic Therapeutic Agent in Myelodysplastic Syndromes (MDS). Int. J. Mol. Sci. 2022, 23, 411.
https://doi.org/10.3390/ijms23010411
AMA Style
Xie X, Frank D, Patnana PK, Schütte J, Al-Matary Y, Liu L, Wei L, Dugas M, Varghese J, Nimmagadda SC,
et al. Curcumin as an Epigenetic Therapeutic Agent in Myelodysplastic Syndromes (MDS). International Journal of Molecular Sciences. 2022; 23(1):411.
https://doi.org/10.3390/ijms23010411
Chicago/Turabian Style
Xie, Xiaoqing, Daria Frank, Pradeep Kumar Patnana, Judith Schütte, Yahya Al-Matary, Longlong Liu, Lanying Wei, Martin Dugas, Julian Varghese, Subbaiah Chary Nimmagadda,
and et al. 2022. "Curcumin as an Epigenetic Therapeutic Agent in Myelodysplastic Syndromes (MDS)" International Journal of Molecular Sciences 23, no. 1: 411.
https://doi.org/10.3390/ijms23010411
APA Style
Xie, X., Frank, D., Patnana, P. K., Schütte, J., Al-Matary, Y., Liu, L., Wei, L., Dugas, M., Varghese, J., Nimmagadda, S. C., & Khandanpour, C.
(2022). Curcumin as an Epigenetic Therapeutic Agent in Myelodysplastic Syndromes (MDS). International Journal of Molecular Sciences, 23(1), 411.
https://doi.org/10.3390/ijms23010411